AU7129700A - Ovarian tumor sequences and methods of use therefor - Google Patents

Ovarian tumor sequences and methods of use therefor

Info

Publication number
AU7129700A
AU7129700A AU71297/00A AU7129700A AU7129700A AU 7129700 A AU7129700 A AU 7129700A AU 71297/00 A AU71297/00 A AU 71297/00A AU 7129700 A AU7129700 A AU 7129700A AU 7129700 A AU7129700 A AU 7129700A
Authority
AU
Australia
Prior art keywords
methods
ovarian tumor
use therefor
tumor sequences
sequences
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU71297/00A
Inventor
John A. Stolk
Jiangchun Xu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Corixa Corp
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/640,173 external-priority patent/US6613515B1/en
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of AU7129700A publication Critical patent/AU7129700A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AU71297/00A 1999-09-10 2000-09-08 Ovarian tumor sequences and methods of use therefor Abandoned AU7129700A (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US39437499A 1999-09-10 1999-09-10
US09394374 1999-09-10
US56177800A 2000-05-01 2000-05-01
US09561778 2000-05-01
US09640173 2000-08-15
US09/640,173 US6613515B1 (en) 1999-09-10 2000-08-15 Ovarian tumor sequences and methods of use therefor
US65666800A 2000-09-07 2000-09-07
US09656668 2000-09-07
PCT/US2000/024827 WO2001018046A2 (en) 1999-09-10 2000-09-08 Ovarian tumor sequences and methods of use therefor

Publications (1)

Publication Number Publication Date
AU7129700A true AU7129700A (en) 2001-04-10

Family

ID=27503365

Family Applications (1)

Application Number Title Priority Date Filing Date
AU71297/00A Abandoned AU7129700A (en) 1999-09-10 2000-09-08 Ovarian tumor sequences and methods of use therefor

Country Status (4)

Country Link
EP (1) EP1212354A2 (en)
AU (1) AU7129700A (en)
CA (1) CA2384499A1 (en)
WO (1) WO2001018046A2 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100543857B1 (en) * 1999-09-01 2006-01-23 제넨테크, 인크. Promotion or Inhibition of Angiogenesis and Cardiovascularization
US6893818B1 (en) 1999-10-28 2005-05-17 Agensys, Inc. Gene upregulated in cancers of the prostate
US20020072503A1 (en) * 2000-03-28 2002-06-13 Jiangchun Xu Compositions and methods for the therapy and diagnosis of ovarian cancer
US6632630B2 (en) 2000-03-29 2003-10-14 Aclara Biosciences, Inc. Monooxygenase assays
AU6531101A (en) * 2000-06-02 2001-12-17 Genentech Inc Secreted and transmembrane polypeptides and nucleic acids encoding the same
US7691567B2 (en) 2000-10-30 2010-04-06 Board Of Regents, The University Of Texas System Methods and compositions relating to fortilin, an anti-apoptotic molecule, and modulators of fortilin
EP2000148A1 (en) 2001-06-20 2008-12-10 Genentech, Inc. Compositions and methods for the diagnosis and treatment of prostate cancer
US20050272120A1 (en) 2001-06-20 2005-12-08 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
US20030120040A1 (en) 2001-06-29 2003-06-26 Genentech, Inc. Secreted and Transmembrane polypeptides and nucleic acids encoding the same
WO2003059256A2 (en) * 2001-12-21 2003-07-24 Idec Pharmaceuticals Corporation Genes overexpresses by ovarian cancer and their use in developing novel therapeutics especially antibodies
NZ535925A (en) * 2002-04-16 2008-06-30 Genentech Inc An isolated antibody that binds to a particular polypeptide
US20050175625A1 (en) 2002-07-12 2005-08-11 The Johns Hopkins University Mesothelin vaccines and model systems
US9200036B2 (en) 2002-07-12 2015-12-01 The Johns Hopkins University Mesothelin vaccines and model systems
US20090110702A1 (en) 2002-07-12 2009-04-30 The Johns Hopkins University Mesothelin Vaccines and Model Systems and Control of Tumors
JP2007511474A (en) * 2003-10-22 2007-05-10 ノバルティス アクチエンゲゼルシャフト Genes involved in neurodegenerative disorders
AR059900A1 (en) 2006-03-17 2008-05-07 Genentech Inc ANTI-TAT226 ANTIBODIES AND IMMUNOCATE PLAYERS

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1630235A3 (en) * 1997-02-25 2009-05-27 Corixa Corporation Compounds for immunodiagnosis of prostate cancer and method for their use

Also Published As

Publication number Publication date
WO2001018046A3 (en) 2001-09-13
CA2384499A1 (en) 2001-03-15
EP1212354A2 (en) 2002-06-12
WO2001018046A2 (en) 2001-03-15

Similar Documents

Publication Publication Date Title
AU4520801A (en) Novel substituted phenanthridinones and methods of use thereof
AU6117000A (en) Novel polynucleotides and method of use thereof
AU3867400A (en) Methods of using bioelastomers
AU3619400A (en) Human prostate cancer associated gene sequences and polypeptides
AU8026600A (en) Brachytherapy instrument and methods
AU2001251358A1 (en) Prion-binding ligands and methods of using same
AU2003200740A1 (en) Compositions and methods for the treatment of tumor
AU2003200722A1 (en) Compositions and methods for the treatment of tumor
AU2003200731A1 (en) Compositions and methods for the treatment of tumor
AU2495200A (en) Compositions and methods for the treatment of tumor
AU2002314466A1 (en) Withasol and methods of use
AU7129700A (en) Ovarian tumor sequences and methods of use therefor
AU3622600A (en) Metalloproteinases and methods of use therefor
AU3623700A (en) Apoptosis inducing molecule ii and methods of use
AU6450398A (en) Sr-bi regulatory sequences and therapeutic methods of use
AU2003215244A1 (en) Complexes and methods of using same
AU2002363938A1 (en) Methods and use of motoneuronotropic factors
AU7832700A (en) Ovarian tumor antigen and methods of use therefor
AU2002227272A1 (en) Ovarian tumor antigen and methods of use therefor
AU5552400A (en) Treatment of cancer
AUPQ367699A0 (en) Treatment of cancer
AU2001296448A1 (en) Tumor marker and methods of use
AU2584699A (en) Immediate early genes and methods of use therefor
AU1199201A (en) Breast tumor sequences and methods of use therefor
AU4021700A (en) Methods of use of beta1-integrin inhibitors

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase